We will be conducting our annual physical inventory from March 11th through March 13th.

Orders received after 4pm CST on Tuesday, March 10th will be scheduled to ship as follows:

US Orders: Ship Saturday, March 14th for arrival on Monday, March 16th.
Canada Orders: Ship Monday, March 16th for arrival on Tuesday, March 17th.

Select items may ship earlier. For questions regarding the status of your order, contact custserv@promega.com.

Engineering circular RNA for enhanced protein production

Publication Date: 17 August 2022

Chen, R. et al. (2022). Engineering circular RNA for enhanced protein production. Nat. Biotechnol. DOI: 10.1038/s41587-022-01393-0


The success of mRNA vaccines has prompted interest in extending the duration of protein expression for gene therapy applications. Circular RNAs (circRNAs), in which coding RNA molecules are joined head to tail, show significant promise in this regard.

In this study, the researchers report the development of a modular high-throughput platform to make and test synthetic circRNAs. To maximize circRNA translation, they optimized five elements: vector topology, 5′ and 3′ untranslated regions, internal ribosome entry sites and synthetic aptamers recruiting translation initiation machinery. To optimize translation activity, they prepared NanoLuc® luciferase reporter constructs and transfected HeLa cells. They also examined circRNA expression levels in vivo by luminescence imaging in mice. The authors conclude that their optimized circRNA synthesis platform increased circRNA protein yields by several hundred-fold and enabled potent and durable protein production in vivo.

Keywords: gene delivery, gene therapy, nucleic acid therapeutics, RNA splicing